The "Chinese Expert Consensus on the Diagnosis and Treatment of Leber Congenital Amaurosis (LCA) 2023" highlights the complexities of diagnosing and treating this rare hereditary retinal disease, which often leads to severe visual impairment. Developed by experts from the Chinese Hereditary Ocular Disease Alliance, the consensus aims to improve understanding of LCA's clinical features, diagnostic methods, genetic testing, and treatment options. Key recommendations include the need for early and accurate diagnosis, the potential of gene therapy, and the importance of genetic counseling for affected families. The consensus stresses that ophthalmologists must be well-informed about LCA to enhance patient outcomes and quality of life.